Skip to main content

Table 5 Survival time by CMS stratified by TNM stage

From: Molecular subtyping improves prognostication of Stage 2 colorectal cancer

 

CMS1

CMS2

CMS3

P-value

Padj

Stage 1

39.8

127.9

110.6

0.035

0.170

Stage 2

108.5

121.8

50.53

0.051

0.006

Stage 3

90.3

72.7

64.4

0.769

0.752

  1. Stage TNM stage, CMS Consensus molecular subtype, Padj P-value adjusted for age, sex, site and side